Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Klin Khir ; (3): 9-11, 2013 Mar.
Artigo em Ucraniano | MEDLINE | ID: mdl-23718024

RESUMO

The investigation objective was to estimate the role of nontraumatic anal sphincter (AS) stretching, as a leading factor of success in minimally invasive and/or plastic proctological interventions. One-centre randomized investigation was performed in 83 patients: In 22 of them the AS fissura was revealed (in 16), suprasphincteric fistula (in 3) and coexistent rectocele 2-3 Ap (according to POP-Q classification) with thinning of the AS anterior segment, the degree III hemorrhoids and anterior AS fissure presence. Ninety units of botulotoxin preparation (Disport) were injected between internal and external AS portions 5-15 days preoperatively. The treatment results without botulotoxin injection were compared retrospectively. After botulotoxin injection performance the AS spasm elimination was noted, leading to the pain subsiding promotion before and postoperatively in all the patients observed. The spasm elimination have permitted to escape the anal high fistula recurrence as a result of the mucosal flap shift after intraluminal closure of the fistula or because of the fistula intermuscular electrowelding "suture" rupture, also have guaranteed the plastic sutures on AS, even while the stage II-III rectocele presence, not depending of performance of its simultant surgica correction.


Assuntos
Canal Anal/efeitos dos fármacos , Toxinas Botulínicas Tipo A/administração & dosagem , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Relaxamento Muscular/efeitos dos fármacos , Espasmo/prevenção & controle , Cirurgia Plástica , Canal Anal/fisiopatologia , Feminino , Fissura Anal/patologia , Fissura Anal/prevenção & controle , Hemorroidas/cirurgia , Humanos , Masculino , Fístula Retal/patologia , Fístula Retal/prevenção & controle , Retocele/patologia , Retocele/prevenção & controle , Recidiva , Espasmo/fisiopatologia , Suturas , Resultado do Tratamento
2.
Fiziol Zh (1994) ; 40(2): 20-6, 1994.
Artigo em Ucraniano | MEDLINE | ID: mdl-7758599

RESUMO

The search of biologically active chemical compounds of the drug was carried out basing on the revealed lymphocytotropic property of splenin. A non-protein factor of the nucleoside origin was isolated from splenin by precipitation with mercury. It had a pronounced direct mitogenic effect on splein and thymic T-lymphocetes, being an active component of the drug. This factor increases the mass of lymphoid organs, promotes restoration of postradiation and steroidogenic lymphocytopenias.


Assuntos
Adjuvantes Imunológicos/farmacologia , Fatores Biológicos/farmacologia , Fígado/efeitos dos fármacos , Sistema Linfático/efeitos dos fármacos , Baço/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Timopoietinas/farmacologia , Timo/efeitos dos fármacos , Animais , Hemoglobinas/análise , Fígado/metabolismo , Sistema Linfático/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos CBA , Ratos , Ratos Wistar , Baço/metabolismo , Linfócitos T/metabolismo , Timo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...